On to the road to degradation: atherosclerosis and the proteasome

Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome

(2009) Hyun-Min Park et al.   ARCHIVES OF PHARMACAL RESEARCH

Cardiovascular Inflammation and Lesion Cell Apoptosis

(2009) Zhaoqing Yang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The functional variant rs1048990 in PSMA6 is associated with susceptibility to myocardial infarction in a Chinese population

(2009) Xin Liu et al.   ATHEROSCLEROSIS

Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2

(2009) Henryk Dreger et al.   CARDIOVASCULAR RESEARCH

A20 Negatively Regulates T Cell Receptor Signaling to NF- B by Cleaving Malt1 Ubiquitin Chains

(2009) M. Duwel et al.   JOURNAL OF IMMUNOLOGY

Oxidized LDL Modulates Apoptosis of Regulatory T Cells in Patients with ESRD

(2009) P. Meier et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

CHIP Represses Myocardin-Induced Smooth Muscle Cell Differentiation via Ubiquitin-Mediated Proteasomal Degradation

(2009) P. Xie et al.   MOLECULAR AND CELLULAR BIOLOGY

The proteasomal system

(2009) Tobias Jung et al.   MOLECULAR ASPECTS OF MEDICINE

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

(2009) Tony Muchamuel et al.   NATURE MEDICINE

Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells

(2009) Muneera R. Kapadia et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Potential Role of CYLD (Cylindromatosis) as a Deubiquitinating Enzyme in Vascular Cells

(2008) Yoichi Takami et al.   AMERICAN JOURNAL OF PATHOLOGY

The −8 UTR C/G polymorphism of PSMA6 gene is associated with susceptibility to myocardial infarction in type 2 diabetic patients

(2008) Michelangela Barbieri et al.   ATHEROSCLEROSIS

Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors

(2008) Deborah J. Kuhn et al.   BLOOD

CD11c + Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4 + T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis

(2008) René R.S. Packard et al.   CIRCULATION RESEARCH

Autophagy in atherosclerosis

(2008) Wim Martinet et al.   Current Atherosclerosis Reports

T cells in arteritis and atherosclerosis

(2008) Cornelia M Weyand et al.   CURRENT OPINION IN LIPIDOLOGY

Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome

(2008) M WU et al.   FREE RADICAL BIOLOGY AND MEDICINE

Proteasome inhibition suppresses essential immune functions of human CD4+T cells

(2008) Carsten Berges et al.   IMMUNOLOGY

A Novel Mechanism by Which Thiazolidinediones Facilitate the Proteasomal Degradation of Cyclin D1 in Cancer Cells

(2008) Shuo Wei et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulatory T-cell immunity and its relevance to atherosclerosis

(2008) S. Taleb et al.   JOURNAL OF INTERNAL MEDICINE

Possible Dual Role of Ubiquitin-Proteasome System in the Atherosclerotic Plaque Progression

(2008) Clara Di Filippo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Potential Role of the Ubiquitin-Proteasome System in Atherosclerosis

(2008) Joerg Herrmann et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Molecular mechanisms of Nrf2-mediated antioxidant response

(2008) Wenge Li et al.   MOLECULAR CARCINOGENESIS

Multiple Interactions between Peroxisome Proliferators-Activated Receptors and the Ubiquitin-Proteasome System and Implications for Cancer Pathogenesis

(2008) Davide Genini et al.   PPAR Research

Proteasome inhibitors: Poisons and remedies

(2007) Silke Meiners et al.   MEDICINAL RESEARCH REVIEWS